T2 Biosystems is classified as operating in the Medical Laboratories industry, NAICS Code 621511.
T2 Biosystems is a publicly traded company on NGM using the ticker symbol TTOO.
Detailed information on company financials and operating reports can be found here:
NGM: TTOO
Note: T2 Biosystems's revenues are gauged from an analysis of company filings.
Investor Activity
T2 Biosystems has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
September 27, 2016
1
100%
$40 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that T2 Biosystems is developing and marketing.
T2 Biosystems doesn't have any recent trademark applications, indicating T2 Biosystems is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
T2SARS-COV-2 Diagnostic reagents for identification and analysis of SARS-CoV-2 virus infections for medical use, medical diagnostic assays for testing biological fluids for SARS-CoV-2 virus infections; medical diagnostic assays for testing of body fluids, namely, assays for use in medical and clinical diagnostics of SARS-CoV-2 virus infections
01/26/2022
T2CAURIS Diagnostic reagents for identification and analysis of Candida auris fungal infections for medical use; medical diagnostic assays for testing biological fluids for Candida auris fungal infections; medical diagnostic assays for testing of body fluids, namely, assays for use in medical and clinical diagnostics of Candida auris fungal infections
02/08/2021
T2AMR Diagnostic reagents for identification and analysis of blood borne bacterial infections for medical use, medical diagnostic assays for testing blood or blood components for blood borne bacterial infections; medical diagnostic assays for testing blood or blood components, namely, assays for use in medical and clinical diagnostics of blood borne bacterial infections
04/15/2020
See all trademarks and details in the Full Report.
Market Share of T2 Biosystems's Largest Competitors
A competitive analysis shows these companies are in the same general field as T2 Biosystems, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to T2 Biosystems.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as T2 Biosystems and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.